GHK-Cu, or copper tripeptide-1, is a small, skin-permeable peptide consisting of glycine, histidine, and lysine bound to copper
GLP-1 Drugs and Eating Disorders: A Hidden Risk in the Weight Loss Revolution By Donnisa Edmonds, C2ST Intern, University of Chicago In 2021, the FDA announced that they had approved Wegovy, a GLP-1 receptor agonist, as a treatment for chronic weight management
Active Monitoring & Ongoing Support Once your weight loss program begins, youll engage in regular follow-up appointments
Write the date you first used the pen on the label or carton so you do not lose track
10.1186/s13058-021-01412-z 81 YokoyamaY.SasakiY.TerasakiN.KawatakiT.TakekawaK.IwaseY.et al (2018)